Site icon Syngene International Ltd

Developing a green synthesis process for a growth promoter drug for animals

Learn how Syngene developed a green synthesis process for a growth promoter drug for an animal health company that reduced the cE factor and PMI value by 80% while achieving high yield and cost-efficiency.

Exit mobile version